Literature DB >> 30267057

Patient Concerns About Nasal Reconstruction After Mohs Surgery and Implications for Shared Decision Making.

John J Chi1, Abby Rosenberg2, Samuel Hahn3, Jay F Piccirillo4,5, Mary Politi6, Dorina Kallogjeri4, Sara Kukuljan4.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30267057      PMCID: PMC6583704          DOI: 10.1001/jamaoto.2018.2368

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


× No keyword cloud information.
  6 in total

Review 1.  The Skindex instruments to measure the effects of skin disease on quality of life.

Authors:  Mary-Margaret Chren
Journal:  Dermatol Clin       Date:  2011-12-20       Impact factor: 3.478

2.  Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.

Authors:  Howard W Rogers; Martin A Weinstock; Steven R Feldman; Brett M Coldiron
Journal:  JAMA Dermatol       Date:  2015-10       Impact factor: 10.282

3.  The importance of communication in collaborative decision making: facilitating shared mind and the management of uncertainty.

Authors:  Mary C Politi; Richard L Street
Journal:  J Eval Clin Pract       Date:  2010-09-12       Impact factor: 2.431

4.  Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011.

Authors:  Gery P Guy; Steven R Machlin; Donatus U Ekwueme; K Robin Yabroff
Journal:  Am J Prev Med       Date:  2014-11-10       Impact factor: 5.043

5.  The skin cancer index: clinical responsiveness and predictors of quality of life.

Authors:  John S Rhee; B Alex Matthews; Marcy Neuburg; Brent R Logan; Mary Burzynski; Ann B Nattinger
Journal:  Laryngoscope       Date:  2007-03       Impact factor: 3.325

6.  Development and psychometric evaluation of the FACE-Q satisfaction with appearance scale: a new patient-reported outcome instrument for facial aesthetics patients.

Authors:  Andrea L Pusic; Anne F Klassen; Amie M Scott; Stefan J Cano
Journal:  Clin Plast Surg       Date:  2013-04       Impact factor: 2.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.